Home›Companies›Biotech & Pharma›Sift Biosciences

Sift Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 22, 2025·Suggest an edit

About Sift Biosciences

Sift Biosciences is a private company based in San Carlos, California, incorporated in 2023 in Delaware. It has reported $3,792,999 raised in one offering on Form D since December 2025. Its chief executive is Yue Lou.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 25, 2025Dec 22, 2025$3,792,999fully sold15$252KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sift Biosciences's Form D filed Dec 22, 2025.

KB
AM
Altar Munis
Director
YL
Yue Lou
Chief Executive Officer and director

Sources

  1. SECSift Biosciences, Inc. filing history